Haibo Shao
Clinical trials sponsored by Haibo Shao, explained in plain language.
-
New quadruple therapy targets liver cancer and diabetes together
Disease control Not yet recruitingThis study tests a combination of four drugs (epalrestat, HAIC, donafenib, and tislelizumab) as a first treatment for people with advanced liver cancer that cannot be removed by surgery and who also have diabetes. The goal is to see if this approach can control the cancer for at …
Phase: PHASE2 • Sponsor: Haibo Shao • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New strategy may boost lung tumor freezing success in High-Risk patients
Disease control Not yet recruitingThis study tests a new approach for lung cancer patients who are at high risk of incomplete tumor freezing during cryoablation. Before the freezing procedure, doctors will block small blood vessels near the tumor using a temporary, absorbable material. The goal is to make the fre…
Phase: NA • Sponsor: Haibo Shao • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC